World TB Day 2025
Unitaid and tuberculosis
Unitaid’s Early Market Access Vehicle – an innovative demand-driven model to catalyze introduction of new optimal health products in low- and middle-income countries
Unitaid and RIGHT Foundation partner to accelerate access to health innovations for low- and middle-income countries
Developing child-friendly TB medicines
More tolerable treatments for drug-resistant TB
Expanded, shortened treatment options are now recommended for all populations with multidrug-resistant tuberculosis (MDR-TB).
Shorter TB prevention regimens (3HP/1HP)
Medicines that clear TB infection from a person’s system before it develops into active disease.